O ORIC PHARMACEUTICALS INC
| Market Cap | $995.75M |
| P/E Ratio | — |
| Forward P/E | -5.74 |
| Dividend Yield | — |
| Beta | 1.36 |
| 52W Range | $4.26 - $14.41 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Viking Global Investors Viking Global Investors | 0.14% | $53.76M | 6,572,691 | Reduce 0.00% |
Insider Trading
| Insider Name of the company insider who made the trade 8 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Piscitelli DominicChief Financial Officer | Sale | 52,000 | $13.51 | $702.69K | 24 Feb 2026 | 26 Feb 2026 |
| Heyman Richard A. | Sale | 3,500 | $12.00 | $42.02K | 16 Jan 2026 | 20 Jan 2026 |
| Heyman Richard A. | Sale | 3,200 | $12.00 | $38.41K | 16 Jan 2026 | 20 Jan 2026 |
| Multani Pratik SChief Medical Officer | Sale | 10,720 | $9.06 | $97.13K | 16 Dec 2025 | 17 Dec 2025 |
| Piscitelli DominicChief Financial Officer | Sale | 10,720 | $9.06 | $97.13K | 16 Dec 2025 | 17 Dec 2025 |
| Chacko JacobPRESIDENT AND CEO | Sale | 33,374 | $9.06 | $302.37K | 16 Dec 2025 | 17 Dec 2025 |
| Chacko JacobPRESIDENT AND CEO | Sale | 37,461 | $12.32 | $461.52K | 06 Oct 2025 | 08 Oct 2025 |
| Piscitelli DominicChief Financial Officer | Sale | 11,000 | $14.52 | $159.72K | 06 Oct 2025 | 08 Oct 2025 |
Frequently Asked Questions
What is ORIC stock price today?
ORIC PHARMACEUTICALS INC (ORIC) is currently trading at $8.89. The stock has a 52-week range of $4.26 to $14.41 and a market capitalization of $995.75M.
Is ORIC a good stock to buy in 2026?
ORIC PHARMACEUTICALS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +69.0%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ORIC stock?
There have been 8 insider transactions for ORIC in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ORIC stock performed over the past year?
ORIC PHARMACEUTICALS INC (ORIC) has returned +69.0% over the past 12 months. The stock traded between $4.26 and $14.41 during this period, and is currently at $8.89.
Which hedge funds own ORIC (ORIC PHARMACEUTICALS INC)?
1 tracked hedge funds currently hold ORIC in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ORIC's market cap and valuation?
ORIC PHARMACEUTICALS INC (ORIC) has a market capitalization of $995.75M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is ORIC's revenue and profitability?
ORIC PHARMACEUTICALS INC reported revenue of N/A with net income of N/A and a profit margin of N/A. The stock has a beta of 1.36.
What sector is ORIC in and who are its biggest institutional holders?
ORIC PHARMACEUTICALS INC (ORIC) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.